Corcept Therapeutics | CORT - Current Assets

Stock Price
32.15
Daily Change
-0.24 -0.74%
Monthly
-18.87%
Yearly
-42.60%
Q1 Forecast
31.18

Corcept Therapeutics reported $485.46M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Acadia Pharmaceuticals USD 1.06B 14.31M Dec/2025
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
ANI Pharmaceuticals USD 753.12M 54.72M Dec/2025
Ardelyx USD 367.98M 16.42M Sep/2025
Assertio Holdings USD 263.57M 53.36M Sep/2025
Aurora Cannabis CAD 423.84M 41.46M Sep/2025
BioMarin Pharmaceutical USD 3.95B 98.95M Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Canopy Growth CAD 445.82M 142.46M Sep/2025
Corcept Therapeutics USD 485.46M 55.67M Dec/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
Esperion Therapeutics USD 360.46M 17.87M Sep/2025
J&J USD 55.62B 1.01B Dec/2025
Knight Therapeutics CAD 397.57M 36.96M Sep/2024
Lexicon Pharmaceuticals USD 145.08M 100.72M Jun/2025
Merck USD 47.56B 10.49B Sep/2025
Nektar Therapeutics USD 281.36M 94.79M Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Omeros USD 69.65M 26.53M Jun/2025
Pacira USD 547.97M 14.78M Dec/2025
Pfizer USD 46.92B 3.22B Sep/2025
Supernus Pharmaceuticals USD 644.18M 50.29M Dec/2025
TG Therapeutics USD 630.76M 31M Dec/2025